Dergiler / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi / 2022 / Cilt: 12 - Sayı: 3

Association of IL-4 and IL-1 Ra Gene Polymorphisms with the Risk of Bladder Cancer

Sayfa
1336–1344
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This study suggest that there were no statistically significant differences determined either in genotype or allele distributions between BC patients and control groups for both IL-4 intron 3 VNTR and IL-1Ra intron 2 VNTR polymorphisms in Turkish population and therefore there was no association of these variants with BC risk in this population.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The aim of this study is to evaluate the association of interleukin-4 (IL-4) gene intron 3 and interleukin-1 receptor antagonist (IL-1Ra) gene intron 2 variable number tandem repeat (VNTR) polymorphisms with bladder cancer (BC) susceptibility in Turkish population.
📊
Temel Bulgular & Veri:A total of 75 BC patients and 126 healthy controls were included in this case-control study.
💡
Sonuç & Katkı:This study suggest that there were no statistically significant differences determined either in genotype or allele distributions between BC patients and control groups for both IL-4 intron 3 VNTR and IL-1Ra intron 2 VNTR polymorphisms in Turkish population and therefore there was no association of these variants with BC risk in this population.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Bladder cancer · VNTR · Polymorphism

Abstract

The aim of this study is to evaluate the association of interleukin-4 (IL-4) gene intron 3 and interleukin-1 receptor antagonist (IL-1Ra) gene intron 2 variable number tandem repeat (VNTR) polymorphisms with bladder cancer (BC) susceptibility in Turkish population. A total of 75 BC patients and 126 healthy controls were included in this case-control study. Genotyping for the interested polymorphisms were analyzed through polymerase chain reaction (PCR). The strength of association between both IL-4 and IL-1Ra gene VNTRs and BC susceptibility was estimated utilizing odds ratio (OR) with corresponding 95% confidence interval (CI). In the study, no statistically significant differences were determined in the allele distributions for either in IL-4 gene intron 3 VNTR (OR= 1.33; CI 0.704-2,41, p=0.390) or in IL-1Ra gene intron 2 VNTR polymorphisms (OR= 0.890; CI 0.569-1.394, p=0.346) between BC patients and control groups. The genotype distributions of IL-4 gene were estimated for RP1/RP2 (OR= 1.55; CI 0.11-7.74, p = 0.590) and RP1/RP1 (OR= 2.08; CI 0.48-9.06, p = 0.320), found no difference between BC and control groups. The genotype distributions of IL-1Ra gene were estimated for 2L (OR= 1.401; CI 0.753-2.610, p = 0.287) and 22 (OR=0.908; CI 0.252-3.276, p = 0.883) and found no difference between BC and control groups. This study suggest that there were no statistically significant differences determined either in genotype or allele distributions between BC patients and control groups for both IL-4 intron 3 VNTR and IL-1Ra intron 2 VNTR polymorphisms in Turkish population and therefore there was no association of these variants with BC risk in this population.

🔖

Bu Makaleye Atıf Yap

POLAT, F., BİNGÖL, G., DİLER, S. B. (2022). Association of IL-4 and IL-1 Ra Gene Polymorphisms with the Risk of Bladder Cancer. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Cilt: 12 - Sayı: 3, 1336–1344. https://ajindex.com/articles/538442

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Ahirwar D, Kesarwani P, Manchanda, PK, Mandhani, A, Mittal, RD, 2008. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer. Cancer Genetics and Cytogenetics, 184(1):1–8.
  2. Ahirwar D K, Agrahari A, Mandhani A, Mittal R D, 2009. Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers, 14(4):213-218.
  3. Ahmed A, Abdelgadir R, Muddathir A, Elshibli EM, Elmula FI, 2006. Interleukin-4 intron 3 VNTR polymorphism gene in leukemic patients. Journal of Blood Disorders & Transfusion, 7(3):100357. Bhayal AC, Krishnaveni D, Rao KPR, Kumar AR, Jyothy A, Nallari, P, et. al., 2015. Significant association of Interleukin4 Intron 3 VNTR Polymorphism with susceptibility to gastric cancer in a South Indian population from Telangana. PloS ONE, 10(9): e0138442. Bid HK, Manchanda PK, Mittal R, 2006. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Urology, 67(5):1099-1104.
  4. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D’Alfonso S, 1999. Cytokine gene polymorphism in human disease: on-line databases. Genes &Immunity, 1(1):3–19.
  5. Briukhovetska D, Dörr J, Endres S, Libby P, Dinarello CA, Kobolt S, 2021. Interleukins in cancer: from biology to therapy. Nature Reviews Cancer, 21: 481-499.
  6. Bozdogan ST, Erol B, Dursun A, Bozdoğan G, Dönmez I, Mungan NA, et. al., 2015. The IL-1RN and IL-4 gene polymorphisms are potential genetic markers of susceptibility to bladder cancer: a case–control study. World Journal of Urology, 33:389–395.
  7. Cai L, Zhang JW, Xue XX, Wang ZG, Wang JJ, Tang SW, et. al., 2014. Meta-Analysis of Associations of IL1 Receptor Antagonist and Estrogen Receptor Gene Polymorphisms with Systemic Lupus Erythematosus Susceptibility. PLoS ONE, 9(10):e109712. Cauci S, Di Santolo, M, Ryckman KK, Williams, SM, Banfi G, 2010. Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status. BMC Medical Genetics,11(1):29. Chu H, Ma L, Wang M, Shi D, Qin C, Yuan L. et al., 2012. The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study. Molecular Biology Reports, 39:5349-57. Dinarello CA, 2018. Overview of